Clinical trial · Interventional
Use of Indocyanine Green in Robotic Prostate Surgeries
Evaluation of the Effect of Intraoperative Indocyanine Green Use on Erectile Function and Surgical Margin Positivity in Patients Undergoing Nerve-Sparing Robot-Assisted Laparoscopic Radical Prostatectomy
NCT05960149CI-TRIAL-00068263unknownPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Imaging of the vascular nerve bundle using Indocyanine Green
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Erectile Dysfunction Following Radical Prostatectomy | — | UNRESOLVED | — |
| Prostate Cancer Adenocarcinoma | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nerve-sparing robot-assisted laparoscopic radical prostatectomy | Procedure | — | UNRESOLVED |
| using Indocyanine Green | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group using Indocyanine Green
- description
- Performing nerve-sparing robot-assisted laparoscopic radical prostatectomy by IV injecting of Indocyanine Green
- interventionNames
- Drug: using Indocyanine Green
- type
- EXPERIMENTAL
- label
- The Indocyanine Green -unused group
- description
- Nerve-sparing robot-assisted laparoscopic radical prostatectomy without the use of Indocyanine Green
- interventionNames
- Procedure: Nerve-sparing robot-assisted laparoscopic radical prostatectomy
Primary outcomes (2)
- measure
- Evaluation of erectile function.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with low-intermediate risk prostate cancer Exclusion Criteria: * Patients high risk prostate cancer
References
Publications (0)
Data not yet available
No reference posted for this study.